What is Intellia Therapeutics's change in AP?

Intellia Therapeutics (NTLA) reported change in AP of -$1.42M in Q1 2026.

How has Intellia Therapeutics's change in AP changed year-over-year?

Intellia Therapeutics's change in AP increased by 24.0% year-over-year, from -$1.87M to -$1.42M.

What is the long-term trend for Intellia Therapeutics's change in AP?

Over 2 years (2021 to 2025), Intellia Therapeutics's change in AP has grown at a 236.4% compound annual growth rate (CAGR), from $529K to $5.99M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Intellia Therapeutics NTLA Change in AP

Change in AP at other companies

Ionis PharmaceuticalsIONS

-$3.1M+88.1%

ALN

Alnylam PharmaceuticalsALNY

-$176.03M-11.6%

CRISPR TherapeuticsCRSP

-$13.02M-130%

Beam TherapeuticsBEAM

$2.22M-41.6%

Iovance Biotherapeutics, Inc.IOVA

$15.89M+674%

Viridian Therapeutics, Inc.VRDN

$4.63M+162%

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.17B+106%

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's change in AP?: Intellia Therapeutics (NTLA) reported change in AP of -$1.42M in Q1 2026.
How has Intellia Therapeutics's change in AP changed year-over-year?: Intellia Therapeutics's change in AP increased by 24.0% year-over-year, from -$1.87M to -$1.42M.
What is the long-term trend for Intellia Therapeutics's change in AP?: Over 2 years (2021 to 2025), Intellia Therapeutics's change in AP has grown at a 236.4% compound annual growth rate (CAGR), from $529K to $5.99M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.